1 / 4

Global Caspofungin Market Size, Share, Future Prospects and Forecast 2020-2026

The global caspofungin market is anticipated to grow at a CAGR of around 5% during the forecast period. The caspofungin is used to treatinvasive candidiasis, invasive aspergillosis, and suspected fungal infections. Caspofungin has a significant application in patients that cannot use or do not respond to other antifungal medications such as amphotericin B, itraconazole.

larebomrglobal
Download Presentation

Global Caspofungin Market Size, Share, Future Prospects and Forecast 2020-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Global Caspofungin MarketShare, Trends, Size, Research and Forecast 2025-2026 Request https://www.omrglobal.com/request-sample/caspofungin-market ------------------------------------------------------------------------------------ a free sample of our report on Global Caspofungin Market: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803040404

  2. The global caspofungin market is estimated to grow at a CAGR of around 5% during the forecast period. The caspofungin drugs work by inhibiting beta-1, 3-D-Glucan which is a necessary enzyme part of the cell wall of a fungus. Candidiasis and Aspergillus are similar fungi whose infection can be treated with the application of caspofungin drugs. This is considered to be a major growth opportunity for the caspofungin market. Moreover, the awareness regarding bacterial infections such as candidiasis and aspergillus is also raising comparatively which will fuel the growth of the caspofungin industry during the forecast period. A full Report of Global Caspofungin Market is Available at https://www.omrglobal.com/industry- reports/caspofungin-market According to CDC estimation, Candidemia, that is the presence of a Candida species, is one of the most common bloodstream infections. Additionally, the average incidence in the US between the period of 2013-2017 was approximately 9 per 100,000 people. Hence, the increasing cases of candidiasis are anticipated to drive the caspofungin market shares. To learn more about this report request a free sample copy @ https://www.omrglobal.com/request- sample/caspofungin-market Additionally, the incidence of life-threatening aspergillus infections across the globe has risen in recent years. Some of the common aspergillus infections among the population include invasive aspergillosis, ABPA CPA, and aspergilloma. Caspofungin was first approved for the treatment of invasive aspergillosis in patients that are intolerant of other therapies. Hence, the rising incidences of various aspergillus infections and the application of caspofungin in its treatment will drive the growth of the caspofungin market. Additionally, the kidney fungal infection was also significantly reduced when treated with caspofungin. This will significantly aid in increasing the caspofungin market share during the forecast period as the prevalence of kidney related disease is raising greatly across the globe. Caspofungin is also used to treat various urinary tract infections that are induced by candida, especially in the infection that iscaused by non-albicans species of Candida. Moreover, Caspofungin’s minimum side effect and low nephrotoxicity are also increasing its adoption to treat fungal infections in patients with compromised renal function. Therefore, the increased adoption of caspofungin drugs in the treatment of various kidney infection will significantly drive the growth of the caspofungin market during the forecast period.

  3. Caspofungin Market- Segmentation By Infection Type Candidiasis Thrush By Dosage Form Powders Ointments Drugs Caspofungin Market-Segment by Region North America US Canada Europe Germany UK France Spain Italy Rest of Europe Asia-Pacific China Japan India Rest of Asia-Pacific Rest of the World Latin America Middle East Africa

  4. Company Profiles Altan Pharma Ltd. Alvogen Centrient Pharmaceuticals Cipla Ltd. Fresenius SE & Co. KGaA LivealthBioPharma Pvt. Ltd. MDA Inc. Merck & Co. Inc. Mylan NV New Xellia Group A/S ParchemFine &Specialty Chemicals Pfizer Inc. Rewine Pharmaceutical Sanofi SA Stanex Drugs and Chemicals Pvt. Ltd. Sun Pharmaceutical Industries Ltd. SVAK Life Sciences Teva Pharmaceutical Industries Ltd. For More Customized Data, Request for Report Customization @https://www.omrglobal.com/report- customization/caspofungin-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803040404

More Related